These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 2559864)
21. Association of sulfonylurea receptor 1 genotype with therapeutic response to gliclazide in type 2 diabetes. Zhang H; Liu X; Kuang H; Yi R; Xing H Diabetes Res Clin Pract; 2007 Jul; 77(1):58-61. PubMed ID: 17118480 [TBL] [Abstract][Full Text] [Related]
22. Metabolic effects of vanadyl sulfate in humans with non-insulin-dependent diabetes mellitus: in vivo and in vitro studies. Goldfine AB; Patti ME; Zuberi L; Goldstein BJ; LeBlanc R; Landaker EJ; Jiang ZY; Willsky GR; Kahn CR Metabolism; 2000 Mar; 49(3):400-10. PubMed ID: 10726921 [TBL] [Abstract][Full Text] [Related]
23. Correction of chronic hyperglycemia with vanadate, but not with phlorizin, normalizes in vivo glycogen repletion and in vitro glycogen synthase activity in diabetic skeletal muscle. Rossetti L; Lauglin MR J Clin Invest; 1989 Sep; 84(3):892-9. PubMed ID: 2503545 [TBL] [Abstract][Full Text] [Related]
24. Effect of the antilipolytic nicotinic acid analogue acipimox on whole-body and skeletal muscle glucose metabolism in patients with non-insulin-dependent diabetes mellitus. Vaag A; Skött P; Damsbo P; Gall MA; Richter EA; Beck-Nielsen H J Clin Invest; 1991 Oct; 88(4):1282-90. PubMed ID: 1918378 [TBL] [Abstract][Full Text] [Related]
25. The impact of metformin therapy on hepatic glucose production and skeletal muscle glycogen synthase activity in overweight type II diabetic patients. Johnson AB; Webster JM; Sum CF; Heseltine L; Argyraki M; Cooper BG; Taylor R Metabolism; 1993 Sep; 42(9):1217-22. PubMed ID: 8412779 [TBL] [Abstract][Full Text] [Related]
26. Studies of gene expression and activity of hexokinase, phosphofructokinase and glycogen synthase in human skeletal muscle in states of altered insulin-stimulated glucose metabolism. Vestergaard H Dan Med Bull; 1999 Feb; 46(1):13-34. PubMed ID: 10081651 [TBL] [Abstract][Full Text] [Related]
27. Ser1369Ala variant in sulfonylurea receptor gene ABCC8 is associated with antidiabetic efficacy of gliclazide in Chinese type 2 diabetic patients. Feng Y; Mao G; Ren X; Xing H; Tang G; Li Q; Li X; Sun L; Yang J; Ma W; Wang X; Xu X Diabetes Care; 2008 Oct; 31(10):1939-44. PubMed ID: 18599530 [TBL] [Abstract][Full Text] [Related]
28. Effects of intensive dietary treatment on insulin-stimulated skeletal muscle glycogen synthase activation and insulin secretion in newly presenting type 2 diabetic patients. Johnson AB; Argyraki M; Thow JC; Broughton D; Jones IR; Taylor R Diabet Med; 1990 Jun; 7(5):420-8. PubMed ID: 2142039 [TBL] [Abstract][Full Text] [Related]
29. Normalization of plasma glucose concentration by insulin therapy improves insulin-stimulated glycogen synthesis in type 2 diabetes. Pratipanawatr T; Cusi K; Ngo P; Pratipanawatr W; Mandarino LJ; DeFronzo RA Diabetes; 2002 Feb; 51(2):462-8. PubMed ID: 11812756 [TBL] [Abstract][Full Text] [Related]
30. Insulin signalling in skeletal muscle of subjects with or without Type II-diabetes and first degree relatives of patients with the disease. Meyer MM; Levin K; Grimmsmann T; Beck-Nielsen H; Klein HH Diabetologia; 2002 Jun; 45(6):813-22. PubMed ID: 12107725 [TBL] [Abstract][Full Text] [Related]
32. Expression of glycogen synthase and phosphofructokinase in muscle from type 1 (insulin-dependent) diabetic patients before and after intensive insulin treatment. Vestergaard H; Andersen PH; Lund S; Vedel P; Pedersen O Diabetologia; 1994 Jan; 37(1):82-90. PubMed ID: 7512060 [TBL] [Abstract][Full Text] [Related]
33. [Glycogen synthetase and non-insulin-dependent diabetes: role of gliclazide]. Lesobre B Journ Annu Diabetol Hotel Dieu; 1991; ():315-21. PubMed ID: 1909395 [No Abstract] [Full Text] [Related]
34. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance. Højlund K Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125 [TBL] [Abstract][Full Text] [Related]
36. Genetic variability of the SUR1 promoter in relation to beta-cell function and Type II diabetes mellitus. Hansen T; Ambye L; Grarup N; Hansen L; Echwald SM; Ferrer J; Pedersen O Diabetologia; 2001 Oct; 44(10):1330-4. PubMed ID: 11692183 [TBL] [Abstract][Full Text] [Related]
37. Effects of growth hormone on fuel utilization and muscle glycogen synthase activity in normal humans. Bak JF; Møller N; Schmitz O Am J Physiol; 1991 May; 260(5 Pt 1):E736-42. PubMed ID: 1903598 [TBL] [Abstract][Full Text] [Related]
38. Oral vanadyl sulfate improves hepatic and peripheral insulin sensitivity in patients with non-insulin-dependent diabetes mellitus. Cohen N; Halberstam M; Shlimovich P; Chang CJ; Shamoon H; Rossetti L J Clin Invest; 1995 Jun; 95(6):2501-9. PubMed ID: 7769096 [TBL] [Abstract][Full Text] [Related]
39. Insulin-mediated glycogen synthase activity in muscle of spontaneously insulin-resistant and diabetic rhesus monkeys. Ortmeyer HK; Bodkin NL; Hansen BC Am J Physiol; 1993 Sep; 265(3 Pt 2):R552-8. PubMed ID: 8214144 [TBL] [Abstract][Full Text] [Related]
40. Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus. Vaag A; Henriksen JE; Beck-Nielsen H J Clin Invest; 1992 Mar; 89(3):782-8. PubMed ID: 1541672 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]